60 participants
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-07-28
- Start Date:
- 2015-09-30
- Completion:
- 2017-04-30
Conditions
- Bipolar Depression
Interventions
- DRUG
- OTHER